Viggars et al offer 3 reasons why they believe the results of our systematic review with meta-analysis assessing probiotic efficacy for prevention of Clostridium difficile infection should be downgraded from high to low or possibly very low quality of evidence on the basis of inconsistency, publication bias, and risk of bias using the GRADE system.1